
Laurie A. Scheiner
Examiner (ID: 16262)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1812, 1807, 1641, 1813, 1648, 1802 |
| Total Applications | 650 |
| Issued Applications | 403 |
| Pending Applications | 88 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 933969
[patent_doc_number] => 06977164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-20
[patent_title] => 'Compositions and kits for Herpes Simplex Virus type 1 and 2 nucleic acid detection'
[patent_app_type] => utility
[patent_app_number] => 10/984301
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 7500
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977164.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984301 | Compositions and kits for Herpes Simplex Virus type 1 and 2 nucleic acid detection | Nov 8, 2004 | Issued |
Array
(
[id] => 7261290
[patent_doc_number] => 20040241143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus'
[patent_app_type] => new
[patent_app_number] => 10/881453
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13669
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881453 | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7238321
[patent_doc_number] => 20040157779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => new
[patent_app_number] => 10/816022
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26410
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816022
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816022 | Prevention and treatment of amyloidogenic disease | Mar 30, 2004 | Issued |
Array
(
[id] => 7462280
[patent_doc_number] => 20040166119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => new
[patent_app_number] => 10/816529
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26396
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166119.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816529
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816529 | Prevention and treatment of amyloidogenic disease | Mar 30, 2004 | Issued |
Array
(
[id] => 793039
[patent_doc_number] => 06982084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-03
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 10/815404
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 26241
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815404 | Prevention and treatment of amyloidogenic disease | Mar 30, 2004 | Issued |
Array
(
[id] => 1106652
[patent_doc_number] => 06808712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-26
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B2
[patent_app_number] => 10/815353
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 26083
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/808/06808712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815353 | Prevention and treatment of amyloidogenic disease | Mar 30, 2004 | Issued |
Array
(
[id] => 7402599
[patent_doc_number] => 20040175394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE'
[patent_app_type] => new
[patent_app_number] => 10/815391
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26409
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815391 | Prevention and treatment of amyloidogenic disease | Mar 30, 2004 | Issued |
Array
(
[id] => 7412511
[patent_doc_number] => 20040176583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus'
[patent_app_type] => new
[patent_app_number] => 10/781599
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22897
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176583.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781599 | Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus | Feb 17, 2004 | Issued |
Array
(
[id] => 985638
[patent_doc_number] => 06924368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => 'Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/726555
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3015
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924368.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726555 | Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same | Dec 3, 2003 | Issued |
Array
(
[id] => 6679063
[patent_doc_number] => 20030229204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'PCG-1, a novel brown fat PPARgamma coactivator'
[patent_app_type] => new
[patent_app_number] => 10/439799
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36289
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10439799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/439799 | PCG-1, a novel brown fat PPARγ coactivator | May 15, 2003 | Issued |
Array
(
[id] => 1009537
[patent_doc_number] => 06900299
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-31
[patent_title] => 'Interrupting the interaction of intercellular adhesion molecule-1 and respiratory syncytial virus for prevention and treatment of infection'
[patent_app_type] => utility
[patent_app_number] => 10/440000
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10537
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10440000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/440000 | Interrupting the interaction of intercellular adhesion molecule-1 and respiratory syncytial virus for prevention and treatment of infection | May 15, 2003 | Issued |
Array
(
[id] => 946520
[patent_doc_number] => 06964852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection'
[patent_app_type] => utility
[patent_app_number] => 10/367677
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4336
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10367677
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/367677 | Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection | Feb 18, 2003 | Issued |
Array
(
[id] => 1155073
[patent_doc_number] => 06764845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-20
[patent_title] => 'Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith'
[patent_app_type] => B2
[patent_app_number] => 10/340389
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8777
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/764/06764845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10340389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/340389 | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith | Jan 9, 2003 | Issued |
Array
(
[id] => 6658612
[patent_doc_number] => 20030078411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Adeno-associated virus capsid immunologic determinants'
[patent_app_type] => new
[patent_app_number] => 10/293478
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4469
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293478 | Adeno-associated virus capsid immunologic determinants | Nov 13, 2002 | Issued |
Array
(
[id] => 7620216
[patent_doc_number] => 06942965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-13
[patent_title] => 'Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/272459
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 13
[patent_no_of_words] => 16075
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/942/06942965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272459
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272459 | Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof | Oct 14, 2002 | Issued |
Array
(
[id] => 1037169
[patent_doc_number] => 06872391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'PGC-1, a novel brown fat PPARγ coactivator'
[patent_app_type] => utility
[patent_app_number] => 10/256889
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 12
[patent_no_of_words] => 36141
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10256889
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/256889 | PGC-1, a novel brown fat PPARγ coactivator | Sep 26, 2002 | Issued |
Array
(
[id] => 1301161
[patent_doc_number] => 06620412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-16
[patent_title] => 'Prophylactic and therapeutic monoclonal antibodies'
[patent_app_type] => B2
[patent_app_number] => 10/202532
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5891
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/620/06620412.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202532 | Prophylactic and therapeutic monoclonal antibodies | Sep 15, 2002 | Issued |
Array
(
[id] => 1357006
[patent_doc_number] => 06569422
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants'
[patent_app_type] => B1
[patent_app_number] => 10/192469
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10670
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192469 | Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants | Jul 9, 2002 | Issued |
Array
(
[id] => 6783710
[patent_doc_number] => 20030065158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Production of novel bovine respiratory syncytial viruses from cDNAs'
[patent_app_type] => new
[patent_app_number] => 10/187790
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10689
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20030065158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10187790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/187790 | Production of novel bovine respiratory syncytial viruses from cDNAs | Jul 2, 2002 | Issued |
Array
(
[id] => 6847053
[patent_doc_number] => 20030166220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'CDNA, GENOMIC, AND PREDICTED PROTEIN SEQUENCES OF LEARNING-INDUCED KINASES'
[patent_app_type] => new
[patent_app_number] => 10/174794
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15363
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174794
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174794 | cDNA, genomic, and predicted protein sequences of learning-induced kinases | Jun 17, 2002 | Issued |